Feedback / Questions
FT011 - Certa Therap, OccuRx
https://www.globenewswire.com/news-release/2024/09/16/2946375/0/en/Certa-Therapeutics-Announces-International-Non-Proprietary-Name-for-its-First-in-class-GPR68-Inhibitor-Asengeprast-FT011.html
Sep 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next